BioSpace News Archive

Drug Development

Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study

Algernon Pharmaceuticals Inc. is pleased to announce that it has filed a combined Clinical Trials of Investigational Medicinal Products and Ethics Approval application, with the United Kingdom Medicines and Healthcare Products Regulatory Agency (“UK MHRA”).

January 19, 2022
·
4 min read
Policy

FDA Accepts for Review Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy for First-line Treatment of Advanced NSCLC

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for PD-1 inhibitor Libtayo.

January 19, 2022
·
17 min read
Business

Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer

Pharmaceutical leader brings over two decades of drug discovery and development in immunology and oncology.

January 19, 2022
·
3 min read
Business

WILLOW BIOSCIENCES PUBLISHES THE FIRST PEER REVIEWED ARTICLE DEMONSTRATING THE CLINICAL BENEFIT OF CBG FOR SKINCARE

Willow Biosciences Inc. is pleased to announce the results of its in vitro analysis and the first to be reported topical clinical study on cannabigerol (“CBG”).

January 19, 2022
·
6 min read
FDA

Nevro Announces FDA Approval for Expanded Labeling for its 10 kHz High Frequency Spinal Cord Stimulation System for Treatment of Non-Surgical Refractory Back Pain (NSRBP)

Nevro Corp. today announced receipt of FDA approval for expanded labeling for its Senza® Spinal Cord Stimulation (SCS) System for the treatment of Non-Surgical Refractory Back Pain (NSRBP).

January 19, 2022
·
5 min read
Business

Ionis strengthens leadership team with appointments of Joseph Baroldi as chief business officer and Eric Bastings, M.D., as vice president, development strategy

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced two appointments that strengthen its leadership team and further position it to become a leading, fully integrated biotechnology company.

January 19, 2022
·
5 min read
Business

Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems

Orthofix Medical Inc today announced a partnership and investment agreement to jointly develop and co-market the innovative nView systems with Orthofix cervical spine and pediatric limb deformity correction procedural solutions.

January 19, 2022
·
5 min read
Pharm Country

Ceptur Therapeutics Launches with $75M Series A Financing to Advance RNA Therapeutics Based on Proprietary U1 Adaptor Technology

Ceptur Therapeutics, Inc. today announced the completion of a $75M Series A financing.

January 19, 2022
·
10 min read
Deals

Bruker Acquires Prolab Instruments to Augment Multiomics Solutions

Bruker Acquires Prolab Instruments to Augment Multiomics Solutions.

January 19, 2022
·
4 min read
Genetown

Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739

Yumanity Therapeutics today announced that, in response to its IND application submitted in December 2021, it was notified via email by the U.S. Food and Drug Administration (FDA) that the FDA has placed a partial clinical hold on multidose clinical trials of YTX-7739.

January 19, 2022
·
6 min read